These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28219794)

  • 1. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.
    Zegkos T; Efthimiadis GK; Parcharidou DG; Gossios TD; Giannakoulas G; Ntelios D; Ziakas A; Paraskevaidis S; Karvounis HI
    Hellenic J Cardiol; 2017; 58(5):331-339. PubMed ID: 28219794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Costabel JP; Galve E; Terricabras M; Ametrano C; Ronderos R; Baranchuk A; Evangelista A; Avegliano G
    Echocardiography; 2018 Jul; 35(7):935-940. PubMed ID: 29505666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kwapiszewska A; Kukula K; Jamiolkowski J; Dabrowski M; Derejko P; Oreziak A; Baranowski R; Spiewak M; Marczak M; Klisiewicz A; Szepietowska B; Chmielak Z; Witkowski A
    Clin Cardiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30120784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.
    Lee SE; Park JK; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
    Heart; 2017 Oct; 103(19):1496-1501. PubMed ID: 28428444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
    Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation.
    Minami Y; Haruki S; Yashiro B; Suzuki T; Ashihara K; Hagiwara N
    J Cardiol; 2016 Dec; 68(6):478-484. PubMed ID: 26908359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.
    Tian T; Wang Y; Sun K; Wang J; Zou Y; Zhang W; Bao J; Zhu L; Shen H; Hui R; Zhou X; Song L
    Cardiology; 2013; 126(4):258-64. PubMed ID: 24157592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
    Tian H; Cui J; Yang C; Hu F; Yuan J; Liu S; Yang W; Jiang X; Qiao S
    BMC Cardiovasc Disord; 2018 Nov; 18(1):207. PubMed ID: 30390664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
    Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
    Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
    Doesch C; Lossnitzer D; Rudic B; Tueluemen E; Budjan J; Haubenreisser H; Henzler T; Schoenberg SO; Borggrefe M; Papavassiliu T
    Int J Med Sci; 2016; 13(1):1-7. PubMed ID: 26812947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.
    Siontis KC; Geske JB; Ong K; Nishimura RA; Ommen SR; Gersh BJ
    J Am Heart Assoc; 2014 Jun; 3(3):e001002. PubMed ID: 24965028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Yashiro B; Minami Y; Terajima Y; Hagiwara N
    J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Vaidya K; Semsarian C; Chan KH
    Heart Lung Circ; 2017 Sep; 26(9):975-982. PubMed ID: 28602671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study.
    Tuluce K; Yakar Tuluce S; Kahya Eren N; Kocabas U; Akyildiz Akcay F; Gunduz R; Akyildiz ZI; Ergene O
    Echocardiography; 2016 Mar; 33(3):379-85. PubMed ID: 26493159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction.
    Liu L; Wu L; Zheng L; Ding L; Chen G; Fan X; Yao Y
    Int Heart J; 2019 Mar; 60(2):327-335. PubMed ID: 30626765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
    Inciardi RM; Giugliano RP; Claggett B; Gupta DK; Chandra A; Ruff CT; Antman EM; Mercuri MF; Grosso MA; Braunwald E; Solomon SD;
    Eur J Heart Fail; 2019 Dec; 21(12):1571-1579. PubMed ID: 31777160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.
    Olivotto I; Cecchi F; Casey SA; Dolara A; Traverse JH; Maron BJ
    Circulation; 2001 Nov; 104(21):2517-24. PubMed ID: 11714644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S; Minami Y; Hagiwara N
    Stroke; 2016 Apr; 47(4):936-42. PubMed ID: 26941260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.